Floating-Harbor syndrome is a rare genetic disorder characterized by specific facial features, short stature, and delayed speech development. It is caused by mutations in the SRCAP gene. The syndrome is typically not inherited, as the mutations usually occur spontaneously. However, in rare cases, it can be inherited from an affected parent. Genetic counseling is recommended for families with a history of Floating-Harbor syndrome to assess the risk of passing it on to future generations.
Floating-Harbor syndrome (FHS) is a rare genetic disorder that was first described in 1973 by Drs. Richard Floating and William Harbor. It is characterized by a distinct set of physical features, developmental delays, and speech difficulties. While the exact prevalence of FHS is unknown, it is estimated to affect less than 1 in 50,000 individuals worldwide.
Causes of Floating-Harbor syndrome:
FHS is caused by mutations in a gene called SRCAP (SNF2-related CREBBP activator protein). This gene provides instructions for making a protein that plays a crucial role in the development and function of various organs and tissues in the body. The specific mutations in the SRCAP gene that cause FHS are typically spontaneous, meaning they occur randomly during the formation of reproductive cells or early embryonic development. These mutations are not inherited from parents and are not passed on to future generations.
Is Floating-Harbor syndrome hereditary?
No, Floating-Harbor syndrome is not hereditary in the traditional sense. It is not passed down from parents to their children in a predictable manner. The mutations that cause FHS are usually not present in the parents and occur randomly during early development.
Genetic testing and diagnosis:
Diagnosing Floating-Harbor syndrome can be challenging due to its rarity and the variability of symptoms. However, genetic testing can help confirm a diagnosis. A blood or saliva sample is collected from the individual suspected of having FHS, and the DNA is analyzed to identify any mutations in the SRCAP gene. It is important to consult with a geneticist or a healthcare professional experienced in genetic disorders to guide the testing process and interpret the results accurately.
Features and symptoms of Floating-Harbor syndrome:
FHS is characterized by a unique combination of physical, developmental, and speech-related features. Some of the common features include:
Management and treatment:
As of now, there is no cure for Floating-Harbor syndrome. Treatment primarily focuses on managing the symptoms and providing support to individuals and their families. Early intervention is crucial, and a multidisciplinary approach involving various specialists, such as geneticists, pediatricians, speech therapists, and psychologists, is often recommended.
Speech therapy can help individuals with FHS improve their communication skills and overcome speech and language difficulties. Educational interventions tailored to the individual's needs can support their intellectual development and maximize their potential. Additionally, addressing any behavioral or psychological issues through appropriate therapies and interventions can greatly improve the quality of life for individuals with FHS.
Conclusion:
Floating-Harbor syndrome is a rare genetic disorder caused by spontaneous mutations in the SRCAP gene. It is not hereditary and does not follow a predictable pattern of inheritance. Genetic testing can help confirm a diagnosis, and early intervention and multidisciplinary care are essential for managing the symptoms and supporting individuals with FHS. While there is currently no cure, various interventions can significantly improve the quality of life for those affected by this syndrome.